
More than 120 countries back treaty to share vaccines in pandemics
World Health Organisation
countries have finally approved a treaty to combat future pandemics, boosting international disease control efforts that are under growing pressure from funding cuts and political rows. Member states of the 194-nation global health body conditionally agreed on Tuesday to ensure countries that shared virus samples would receive disease tests, medicines and vaccines, after many poorer nations suffered shortages during the Covid-19 crisis.
The measures to tackle the resource inequities that blighted the global response to Covid-19 come after rich nations have slashed aid budgets and the US has announced it will leave the WHO. The new pandemic treaty will go for ratification by participant countries once an annex on the long-contentious topic of detecting and sharing data on emerging pathogens is agreed. Tedros Adhanom Ghebreyesus, WHO director general, hailed the treaty as a 'historic' accord that would make the world safer.
'The agreement is a victory for public health, science and multilateral action,' he said. 'It will ensure we, collectively, can better protect the world from future pandemic threats. It is also a recognition by the international community that our citizens, societies and economies must not be left vulnerable to again suffer losses like those endured during Covid-19.'
The pact was backed in Geneva by the WHO's annual World Health Assembly of member states after winning support in a committee vote late on Monday. More than 120 countries supported it with none against, although 11 abstained, including Poland, Israel, Italy, Russia, Slovakia and Iran.
READ MORE
The agreement, originally meant to be finalised a year ago, aims to improve international mechanisms for pandemic prevention, preparedness and response. The deal sets out a provisional mechanism in which participating drugs companies would aim to make 20 per cent of their real-time production of pandemic vaccines, medicines and diagnostic tests available to the WHO. These would be distributed according to public health risks and needs, with a particular focus on developing countries.
This mechanism – known as the Pathogen Access and Benefit Sharing system (Pabs) – will now go to an international working group to be drafted and negotiated for consideration at next year's World Health Assembly.
An agreement on Pabs has been delayed by disagreements over proposals for pharmaceutical companies to fund the monitoring of new pathogens, which should in turn speed up efforts at vaccine development.
The pharmaceutical industry lobby group said the treaty was just a 'starting point', and its success would depend on how it was implemented.
The WHO international working group will also work on setting up a financial mechanism and global supply and logistics network to support the treaty's efforts. When Covid-19 vaccines were rolled out starting at the end of 2020, many poorer countries had only meagre supplies after richer nations bought up most of the doses.
The pandemic accord has drawn criticism from conservatives in the US and other countries. They have attacked it as a threat to government sovereignty on health policy and intellectual property protection, although the pact's supporters say it is neither.
The accord says that it does not provide the WHO with any authority to dictate government policies in areas such as travel restrictions, vaccination mandates or lockdowns.
International health experts welcomed the pandemic accord, but some queried whether all countries would comply – and, if not, what mechanisms would force them to do so. − Copyright The Financial Times Limited 2025
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Irish Daily Mirror
13 hours ago
- Irish Daily Mirror
Three new Covid symptoms flagged as NB.1.8.1 strain may be different
Experts have identified three important symptoms of the latest Covid strain to reach the UK. The latest signs to look out for may be different to typical virus expectations. While it has been over five years since the pandemic first made waves, coronavirus hasn't gone away and continues to impact people across the globe as it mutates into different variants. The latest strain, known as NB.1.8.1, has spread in several countries, including major holiday destinations, after being identified earlier in January as a follow on from the Omicron variant. The Health Protection Surveillance Centre (HPSC) reports that Covid samples linked to NB.1.8.1 has risen from 3.7 to 33 percent in the past five weeks alone. In addition, it is also a "variant under monitoring" by the World Health Organisation (WHO) because of its rapid spreading, reports the Mirror. While Covid symptoms have been heavily associated with the respiratory system, such as struggling to breath and coughing, NB.1.8.1 symptoms are related to the digestive system. It now accounts for more than 10 per cent of sequenced Covid infections worldwide and is already the dominant strain in China and Hong Kong. The variant has also been detected in the UK, US and Australia, as well as a number of popular holiday destinations like Egypt, Thailand, and the Maldives. Writing for The Conversation, Dr Lara Herrero, associate professor and virology research leader at Griffith University in Australia, explained that this variant could be faster spreading than others. She said: 'The evidence so far suggests NB.1.8.1 may spread more easily and may partially sidestep immunity from prior infections or vaccination. 'These factors could explain its rise in sequencing data.' However, she added: 'But importantly, the WHO has not yet observed any evidence it causes more severe disease compared to other variants.' Many of us are aware of the 'classic' symptoms of a Covid injection, such as a cough, sore throat, an aching body and loss of taste or smell. However, there could be some lesser-known symptoms linked to the NB.1.8.1. 'Reports suggest symptoms of NB.1.8.1 should align closely with other Omicron subvariants,' Dr Herrero said. She added that gastrointestinal symptoms could occur in some cases. As reported by The Independent, these could include: This could mean that it is easier to mistake a Covid infection for a different illness. But Dr Herrero added that this variant could also be accompanied by a sore throat, fatigue, fever, mild cough, muscle aches and nasal congestion. While there are no longer any self-isolation mandates in the UK, the NHS recommends avoiding contact with others if you experience symptoms. It says you should try to stay at home and avoid contact with other people if you or your child has symptoms and either: You can go back to your normal activities when you feel better or do not have a high temperature. But if you test positive, you should:

The Journal
a day ago
- The Journal
Gaza's health system 'collapsing' as Israel plans to block access to two major hospitals
GAZA'S HEALTH SYSTEM is 'collapsing' with two of the largest hospitals still operating in the territory at risk of becoming non-functional, according to the World Health Organization (WHO). Nasser Medical Complex and Al-Amal Hospital in southern Gaza lie just within or just outside evacuation zones mandated by the Israeli government and military. Most of the population also currently live in the hospital's facilities, the WHO said. 'Without them, people will lose access to critical health services,' it added. At least 37 people were killed in Israeli strikes in Gaza last night, according to the territory's civil defence agency. It reported attacks up and down the length of the region. The Israeli military did not immediately respond to the AFP agency request for comment. Advertisement International calls for a negotiated ceasefire have grown in recent weeks, particularly as the humanitarian situation in the devastated Palestinian territory has worsened. Last night, the US vetoed a Security Council resolution calling for a truce. Israel has faced mounting international pressure to allow more aid into Gaza, after it imposed a more than two-month blockade that led to widespread shortages of food and other essentials. Nasset and Al-Amal hospitals have not received orders to evacuate patients or staff, but Israeli authorities have informed the Ministry of Health that access routes leading to both hospitals will be obstructed, WHO said. 'As a result, safe access for new patients and staff will be difficult, if not impossible,' it added. 'If the situation further deteriorates, both hospitals are at high risk of becoming non-functional, due to movement restrictions, insecurity, and the inability of WHO and partners to resupply or transfer patients.' With reporting by AFP Readers like you are keeping these stories free for everyone... A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation. Learn More Support The Journal


Irish Times
2 days ago
- Irish Times
SOS cancer hotline making ‘a real, tangible difference in the lives of people going through chemotherapy'
An SOS hotline has saved Pauline Doyle, who is being treated for breast cancer , from many trips to a hospital emergency department over the past two years. In this case, SOS stands for Sort Out my Symptoms and it was an initiative that was kick-started by the Covid-19 pandemic. Five years on, this early intervention service has more than proved its worth in keeping vulnerable cancer patients in active treatment away from extra visits to hospital if at all possible, or at least bypassing the ED. 'It is the nearest thing we have to scheduling non-scheduled care,' says Maria Gillespie, assistant director of nursing for what is formally known as the Acute Haematology Oncology nursing Service (AHOS). It started in 2020, when the National Cancer Control Programme received funding for a designated nurse specialist in each of the 26 hospital cancer centres around the State . They were to be available at the end of a phone line for patients in treatment who felt unwell at home. It has grown as a national network since, standardising the approach to ensure there is no so-called 'postcode lottery' at play in this aspect of care. Identical information leaflets and alert cards are handed out at each centre and are available in 10 languages. An additional 18 nurse specialists are now being recruited to bolster the service in the busiest hospitals. READ MORE 'In 2020, we received 1,137 calls,' says Gilliespie. 'Last year, in 2024, we received 21,873 calls. We know it works.' Pauline Doyle. Doyle, who lives in Drumsna, Co Leitrim, and attends St James's Hospital in Dublin for her cancer treatment, says the SOS hotline is something that makes 'a real, tangible difference in the lives of people going through chemotherapy'. She was diagnosed at the end of 2023, after finding a lump in a breast and going to her GP. A mother of two children, aged 10 and 12, she had six months of pre-surgery chemotherapy, followed by radiotherapy after her surgery. She is currently undergoing one year of post-surgery chemotherapy, for which she visits St James's once every three weeks. 'From very early on, and I think this is probably a lot of people's experience, I've had issues with my chemo, and difficulty managing side effects. I've required [hospital] admission a few times. So to have this service has been absolutely invaluable. It has kept me away from the emergency department on lots of occasions. [ I was completely numb and couldn't take it in - I didn't think I would hear the words, 'sorry, you have breast cancer' Opens in new window ] 'It's amazing to have somebody at the end of the line that knows you, that knows your case, that knows your history. Sometimes it's something small. All you need is a piece of advice – take this medication, take that medication. Other times it's, 'Come in and we'll see you.'' If a patient does need to go in after being triaged over the phone, they can go straight to the cancer ward to be seen by that nurse, who will then get a doctor to review them. Blood tests can be done immediately. At the outset of treatment, Doyle, who is currently on leave from work as a mental health nurse, was allergic to her first chemotherapy drugs. 'I came out in very bad skin rashes.' She was ringing the hotline for management of that and the dermatology service was organised to see her as soon as she went in. She has experienced various health issues since, the most recent proving to be a chest infection. Again, the call to the nurse specialist ensured they were all ready for her after she was advised to come in. 'I attended with persistent coughing and they got me a chest X-ray and bloods organised straight away. They could give me the all clear that day, start me on the course of medication and get me turned around and home within an hour or two.' Doyle does not like to think how long all that might have taken if she had gone through the ED, which she has had to do on occasion if in trouble over the weekend when the nurse specialist was off. While she stresses that the ED staff are fantastic, the difference between going through ED and using the SOS hotline is 'night and day'. Gillespie is full of enthusiasm for how well the service is working. 'Really strong foundations have been laid and we're well positioned to grow.' Maria Gillespie, AHOS assistant director of nursing However, she is also mindful that 'the current model is really vulnerable' because many of the cancer centres still have just one nurse providing the service. There is no cover at weekends or during their six weeks of annual holidays. 'When that nurse goes on leave, the impact is instant,' she says. There are plans to build it up into a 24/7 service, but, in the meantime, they have decided to use the allocation of €700,000 ring-fenced annual funding for the 18 additional posts to strengthen it Monday to Friday. 'We've done a really detailed health needs assessment for where we allocate those,' says Gillespie, who explains how the AHOS works. It was adopted from a system that has been operating in the UK for 20 years. Anybody receiving cancer treatment, be that chemotherapy, immunotherapy or radiotherapy, is informed by a nurse specialist about the possible side effects. They are also given a dedicated SOS hotline number to ring if they have any worries and issues such as high or low temperature, nausea, diarrhoea, vomiting, fatigue, anorexia, constipation, urinary symptoms. During the phone call they will be triaged through a standardised system. The next steps are planned according to that assessment. If it's a 'red' symptom, such as a fever, that patient requires an urgent, in-hospital check. 'It can signal an infection and/or sepsis and both of them can be life-threatening for cancer patients.' [ Breakthrough by DCU researcher promises improved 'chemo' with fewer side effects Opens in new window ] If it's an 'amber' assessment, that means the patient has to be seen within 24 hours. However, if the patient has two ambers, then the nurse specialist will escalate them straight away to a red. A 'green' symptom is a side effect that can be managed at home with self-care and follow-up advice. There are no 'wrong' reasons for using the hotline, she stresses, and over time a trusting relationship builds up between the patient and their nurse specialist. Video-enabled care is also being rolled out as part of this service, after a successful pilot project that was started in Naas hospital last year. In nearly 20 of the cancer centres the nurse specialist now has a widescreen monitor on which they review symptoms that can be shown by a patient using their smartphone or other device. The ability to view common problems, such as a sore mouth or infected Hickman line (tube into vein), makes a significant difference in the accuracy of assessment gradings. 'That early intervention is key; being able to actually see patients, that prevents the symptom from becoming worse,' says Gillespie. 'It prevents the patient having to call an ambulance the following day and somebody being in a totally different situation.' Previously, patients may have delayed seeking care because they could not face going through ED. 'There will always be times when patients have to go to the emergency department, if someone has chest pain, for example,' says Gillespie, 'but it's really to avoid as many visits as possible. Cancer patients don't belong in the ED.' The AHOS staff love their jobs, she says, because they can see the very positive benefits for patients. Every time she visits one of the hospitals involved, she always drives away reflecting on the 'phenomenal' impact that one nurse specialist can make. 'The service shows what's possible,' she adds, 'when you put patient-centred design, national leadership and expert nursing together.' From her personal experience, Doyle wholeheartedly supports further resourcing of the SOS hotline network, towards a 24/7 operation. 'When you're really struggling with side effects, it means an awful lot to be able to access a service like this that can look after you and that know you, and that you're not waiting in a big system to get through.'